Skip to main content
Premium Trial:

Request an Annual Quote

David Danley, Jay Johnston, Gerard Vaillant, Laurence Hirsch, Thomas Caskey

Premium

David Danley has joined the board of directors of therapeutic antibody firm Hematech, the Sioux Falls, SD-based company said last week. He is the director for homeland security and defense programs at CombiMatrix. Prior to that, he was project manager of the chemical biological medical systems and joint vaccine acquisition program for the Department of Defense.


Jay Johnston and Gerard Vaillant have joined the board of directors of Luminex, the Austin, Texas-based company said last week. Laurence Hirsch and Thomas Caskey will retire from the board before this summer.

Johnston is chairman of QuesTek Innovations. In the past, he was corporate vice president for diagnostic assays and systems at Abbott Laboratories. He holds an MBA in general management from Amos Tuck School of Business Administration and an BA degree in public administration from Dartmouth College.

Until he retired last year, Vaillant was company group chairman of Johnson & Johnson He holds a master’s degree and superior certificate in biochemistry and industrial chemistry from Paris University of Sciences and a degree in marketing from Ecole Superieure de Commerce de Paris.

 

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.